| Target |
p185erbB2, HER2, NGL, Tyrosine kinase-type cell surface receptor HER2, NEU, MLN 19, Proto-oncogene Neu, MLN19, ERBB2, Proto-oncogene c-ErbB-2, CD340, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein |
| Function |
InVivoMAb Anti-Human CD340/ERBB2/HER2/NEU Antibody (520C9)[520C9] (ARO-A13115) is amouse monoclonalantibody detectingp185erbB2, HER2, NGL, Tyrosine kinase-type cell surface receptor HER2, NEU, MLN 19, Proto-oncogene Neu, MLN19, ERBB2, Proto-oncogene c-ErbB-2, CD340, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 proteininBlocking, ELISA. Suitable forHuman.HighlightsProtein A/G purified from cell culture supernatant.— Ensuring high specificity and minimal background.Multi-Application— Validated across multiple applications. |
